The Suda, the massive tome written by a Byzantine scholar around the year 1100, was one of the world's first encyclopedias and lexicons.

Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Lexicon Pharmaceuticals LXRX in the last three months. The following table summarizes their ...

Eventually, nine muses were identified, covering every branch of the arts, in the ancient Greek poet Hesiod’s introduction to Theogony, his epic poem about mythical stories and characters (circa ...

PITTSBURGH, Oct. 16, 2024 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it has entered into an exclusive licensing agreement with Lexicon ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Lexicon Pharmaceuticals (LXRX – Research Report), with a price target of $10.00. The company’s shares ...

To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Lexicon Pharmaceuticals is selling rights to its only marketed drug outside of the U.S. and Europe amid a ...

Credit: Jo Panuwat D/Shutterstock. Lexicon Pharmaceuticals has entered a licensing agreement with Viatris, granting the latter exclusive rights to commercialise sotagliflozin in all indications ...

Credit: AMNA The Greek national football team achieved its first victory ever on English soil in an UEFA Nations League game against the “Three Lions” on October 10, 2024, with Vangelis Pavlidis as ...